US-based medical technology firm Omega Medical Imaging has received marketing approval from the US Food and Drug Administration (FDA) for its Soteria.AI, an image-guided X-ray system specifically designed for interventional cardiology labs. This marks a significant milestone as Soteria.AI is hailed as the first artificial intelligence (AI)-enabled X-ray system approved for use in cardiology around the world.
Innovative AI Technology for Enhanced Diagnostics and Patient Care
Soteria.AI utilizes deep learning and AI technologies to analyze and recognize X-ray images, providing more accurate diagnostic results. Its image guidance function is a game-changer, assisting doctors in better locating lesion sites while reducing radiation exposure and surgical time. This advancement in medical imaging technology is set to improve patient outcomes by minimizing the risks associated with radiation exposure during diagnostic procedures.
Reducing Radiation Dose with Soteria.AI
The product’s capability to significantly reduce radiation dose by about 84% is a testament to its potential impact on patient care. By offering a more precise and safer imaging solution, Soteria.AI is poised to become an invaluable tool in the field of interventional cardiology.-Fineline Info & Tech
